Status:
COMPLETED
Follow-up Data of Patients Treated With XIGRIS® in France
Lead Sponsor:
Eli Lilly and Company
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
The transparency commission wishes that the laboratory Lilly France sets up a follow-up study describing the conditions of use of Xigris® in France. The purpose of this study is to describe the chara...
Detailed Description
The objectives of the study as defined by the specific requirements of Transparency Commission are as follows: * To describe the characteristics of the patients treated with Xigris® * socio-demogr...
Eligibility Criteria
Inclusion
- Patients are eligible to be included in the study if they meet the following criteria
- Patients treated with Xigris® during the study period in intensive care units in France
- Patients with a minimum age of 18 years
- Patients who are presenting in the normal course of care
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT00803231
Start Date
November 1 2008
End Date
December 1 2009
Last Update
February 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this study, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Suresnes, France